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Sedentary behavior, particularly sitting, is ubiquitous in many contemporary societies.
This is a major societal concern considering the evidence for a strong association
between sitting behavior and cardiovascular disease morbidity and mortality.
Unsurprisingly, leading public health agencies have begun to advocate “reduction” in
sitting behavior. Though, the guidelines are typically vague and non-specific. The lack
of specific guidelines for prolonged sitting is attributable to the absence of available
evidence to facilitate guideline development. To inform policy, well-designed randomized
controlled trials are required to test the efficacy of specific and translatable sitting
reduction strategies. To guide the design of randomized controlled trials, this review
postulates that several gaps in the literature first need to be filled. Following a general
discussion of the importance of sitting behavior to contemporary societies, each of
the following are discussed: (i) acute sitting exposure and systems physiology; (ii)
recommendations for a systems physiology toolbox; (iii) study design considerations for
acute sitting exposure; and (iv) translation of sitting-focused research.
Keywords: biological plausibility, ecological validity, external validity, internal validity, methodology, sedentary
behavior, arterial stiffness, endothelial function
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INTRODUCTION
Sedentary behavior (SB), particularly sitting, is ubiquitous in
many contemporary societies (Figure 1) (1). This is a major
societal concern in light of the evidence for a strong association
between SB and cardiovascular disease (CVD) mortality.
However, while leading public health agencies, including the
World Health Organization (WHO), have begun to advocate
“reduction” in SB, the guidelines are typically vague and non-
specific (2, 3). To inform SB policy, well-designed cohort
studies and randomized controlled trials (RCTs) are needed
(see Figure 2) to test the efficacy of specific and translatable
SB reduction strategies. To assist in the design of RCTs,
this review postulates that several gaps in the literature first
need to be filled. Following a general discussion of the
importance of SB to contemporary societies, each of the following
are discussed:
(i) Acute SB exposure and systems physiology, i.e., how and
why SB increases CVD risk.
(ii) Systems physiology toolbox, i.e., methods to investigate
the effects of acute SB exposure on systems physiology.
The flow-mediated dilation (FMD) and pulse wave velocity
(PWV) test are used as exemplars to provide context to the
key considerations that need to be made.
FIGURE 1 | Example of a typical 24-h activity cycle for individuals in modernized economies. The average adult engages in sedentary behaviors (SB) ∼half their
waking hours, with the majority of the remaining waking hours engaged in light physical activity (LPA). Time spent in moderate-to-vigorous physical activity (MVPA) is
typically minimal (∼3% of the day), even for adults meeting recommended levels.
(iii) Study design consideration, i.e., how to design an acute SB
study with forethought to internal validity, external validity,
and ecological validity. The FMD and PWV tests are further
used to provide context.
(iv) Translation, i.e., steps to increase the likelihood of SB-
focused research informing policy.
While some basic context is provided, it is not the intention of
this review to comprehensively discuss the historical and socio-
cultural considerations, or to comprehensively discuss potential
mechanistic pathways. For clarity, the intention of this review
is to provide a primer for important considerations to assist in
the design of acute SB studies. Table 1 presents a glossary of
terms, provided to assist in the interpretation of concepts specific
to the sitting literature and discussed within this review. This
review should be viewed as an addition to existing research design
guidelines, including the Consolidated Standards of Reporting
Trials (CONSORT) (4).
IMPORTANCE OF SEDENTARY BEHAVIOR
TO SOCIETY
Since the mid-20th century, societal changes have led to
increased SB, particularly sitting (5). Today, the average
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FIGURE 2 | Pyramid of clinical evidence. With respect to sedentary behavior-focused research and the capacity to develop sedentary behavior-reduction policy, we
are currently sitting somewhere near the bottom of the pyramid peering up.
American spends 55% (7.7-h/day) of their waking time sedentary,
with much of that time spent sitting, and inactive (1). The
terms “physical inactivity” and “sedentary behavior” have been
used interchangeably. However, physical inactivity refers to
not meeting moderate-to-vigorous physical activity (MVPA)
guidelines, and SB refers to very low intensity behaviors (≤1.5
metabolic equivalents) in a seated, reclined, or supine posture (6).
SB is a distinct CVD risk factor (1, 7), and interrupting SB with
light intensity physical activity has health benefits independent
from MVPA (8, 9). Despite SB being a large part of our daily
behavior (see Figure 1), public health programs and policies have
primarily focused on other modifiable health behaviors, such
as diet, smoking, and MVPA. Little is known about optimal
prescription for reducing SB (2).
Using MVPA as an exemplar, the 2018 Physical Activity
Guidelines provide a clear public healthmessage: “For substantial
health benefits, adults should do at least 150min per week. . . of
moderate-intensity. . . aerobic physical activity” (2). These
guidelines, which are based on the FITT (frequency, intensity,
time, and type) principle, are driven by numerous RCTs and
subsequent meta-analyses exploring the health benefits of
physical activity (2). Such RCTs and meta-analysis data are
unavailable for SB. However, it should be acknowledged that,
while the first physical activity study was published in 1953
(10), SB-focused research is in its infancy. As such, the 2018
Physical Activity Guidelines do recommend sitting less, based on
the “strong” overall and dose-response association between SB
and CVD mortality, but they do not provide specific guidelines
for sitting substitution (2). The absence of specific guidelines
can be attributed to the fact that very few studies, mostly
cross-sectional, have investigated the physiological mechanisms
of SB and its association with CVD. This incomplete mechanistic
understanding limits the ability to identify informed sitting-
interruption strategies. The next part of this review will briefly
discuss plausible physiological mechanisms, specifically as they
relate to sitting behavior, followed by an overview of available
tools to investigate these mechanisms.
SYSTEMS PHYSIOLOGY AND ACUTE
EXPOSURE TO PROLONGED SITTING
To provide context to the sections that follow, this section briefly
outlines a plausible working model for the relationship between
acute prolonged sitting exposure and negative cardiovascular
responses. The primary outcome of this model, depicted in
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TABLE 1 | Glossary of terms.
Term Definition
24-h activity cycle Activities conducted over a 24-h period including, sleep, sedentary behavior, light-intensity physical activity, and
moderate-to-vigorous physical activity.
Accuracy (Validity) Deviation of a measure from its true value, including systematic (constant bias) and random error (variable) components.
Arterial stiffness Fundamental mechanical behavior or rigidity of the material properties of the artery wall, determined by both structural and
functional components.
Biological plausibility Proposal of a causal association (or relationship between a cause and outcome) that is consistent with existing biological and
medical knowledge.
Cardiovascular disease (CVD) A general term for pathologies affecting the heart or blood vessels, including cerebrovascular disease, myocardial infarction,
coronary heart disease, and peripheral artery disease.
Exercise A subset of physical activity that is planned, structured, and repetitive.
Ecological validity The degree to which results obtained from research or experimentation are representative of conditions in the wider world.
Endothelial function The ability of the endothelium to adequately perform its physiological roles in maintaining homeostasis.
External validity The degree to which causal relationships can be generalized to different measures, persons, settings, and times.
Intermediate outcome A surrogate measure (e.g., pulse wave velocity) used to measure the effect of a treatment that may correlated with a real clinical
endpoint (e.g., cardiovascular disease).
Internal validity Degree to which a study establishes the cause-and-effect relationship between the treatment and the observed outcome.
Metabolic equivalent (MET) Unit used to describe the absolute intensity of physical activity. A ratio of your working metabolic rate relative to your resting
metabolic rate.
Physical activity Any bodily movement produced by skeletal muscles that requires energy expenditure.
Physical inactivity An insufficient level of moderate-vigorous physical activity level to meet present physical activity recommendations.
Policy A course or principle of action adopted or proposed by an organization or individual.
Precision (Reliability) Dispersion of a measurement or degree to which a measure contained on one occasion is repeated on a second occasion,
including intra-rater (test-retest) and inter-rater components.
Randomized controlled trial (RCT) People are randomly assigned to two (or more) groups, typically including one control and one or more experimental groups.
Sedentary behavior (SB) Any waking behavior characterized by an energy expenditure ≤1.5 METs, while in a sitting, reclining or lying posture.
Translation The use of scientific evidence by decision makers to inform and generating health policy.
Figure 3, is aortic arterial stiffness, a measure explained in further
detail below and that we have reported to increase in response
to uninterrupted prolonged sitting (11–14). The elastic aorta is
directly proximal to the heart and is responsible for dampening
the speed and amplitude of retrograde pressure waves that
increase the heart’s workload during systole (myocardial burden)
(15). This measure is particularly appealing because arterial
stiffness is a multifactorial measure of central hemodynamics,
dependent on blood pressure and intrinsic arterial structural
and functional properties (15). Therefore, an increase in aortic
arterial stiffness not only signifies increased myocardial burden
and target organ damage susceptibility, but also reflects the stress
being placed on the aorta and the potential for detrimental
changes to the vessel.
Our working hypothesis is that acute sitting-induced increases
in arterial stiffness are likely driven by local hemodynamic
changes and compounded by a number of detrimental
autonomic, hormonal, and metabolic factors. With respect
to hemodynamics, we have reported that hydrostatic pressure
and lack of muscle pump activity led to lower extremity venous
blood pooling, the slower transit time of blood through the
venous circulation, which decreased venous return and was
inversely associated with stroke volume (16). This decreased
stroke volume in turn reduces shear stress (17, 18), the primary
regulator of endothelial function (19). Decreased shear stress
promotes oxidative stress, endothelial dysfunction, and acutely
increases aortic arterial stiffness (20–24). As mentioned above,
the increased aortic stiffness may exacerbate myocardial burden
as a function of the increased speed and amplitude of retrograde
pressure waves. Changes to peripheral vessels, particularly in the
lower-limbs, may compound the retrograde pressure waves. In
support, we reported endothelial dysfunction (25) and increased
arterial stiffness in the legs (26). Lower-limb leg endothelial
dysfunction is induced by the pro-atherogenic shear stress
profile as a result of decreased stroke volume and alterations in
vascular resistance near tortuous vessels (27–29).
Autonomic and hormonal changes further elevate aortic
arterial stiffness by increasing systemic vascular resistance
(30). The autonomic changes are driven by reduced pressure
along the arterial baroreceptors, and the hormonal changes by
reduced blood pressure along the kidneys, which stimulates
the renin-angiotensin aldosterone system (31). Metabolically,
lack of muscle contractile stimulation suppresses lipoprotein
lipase activity—required for triglyceride uptake and high-
density lipoprotein production—and glucose uptake (32, 33).
Elevated plasma glucose promotes higher circulating insulin
concentrations, which contribute to arterial stiffness via a
combination of enothelin-1 release from mitogen-activated
protein kinase activation, and centrally-mediated adrenergic
vasoconstriction (34).
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FIGURE 3 | Hypothesized mechanisms linking repeated prolonged sedentary behavior (sitting) exposure to cardiovascular disease.
The hemodynamic, autonomic, hormonal, and metabolic
changes briefly described in this section lead to acutely increased
aortic arterial stiffness. However, we hypothesize that repeated
increases in arterial stiffness leads to structural remodeling of
vessel walls (15), and this helps to explain, in part, the positive
association between chronic SB and aortic arterial stiffness (35),
and between SB and CVD (2, 3).
SITTING TOOLBOX
Table 2 outlines example tools available to acute sitting-focused
researchers and relates these tools to the working model outlined
in Figure 3. At the end of this section, we provide further
details of two commonly used tools, FMD and PWV, which will
subsequently be further discussed in terms of internal validity
in the proceeding section Internal Validity Considerations. As
outlined in Table 3, when selecting appropriate tools, a number
of considerations need to be made, starting with “what is your
research question?” Is the purpose to elucidate the mechanisms
by which acute prolonged sitting exposure leads to increased
myocardial burden? If so, which tool(s) can reflect themyocardial
burden, and which physiological systems are contributing to
this burden? Additionally, are these physiological changes
systemic, such as hormonal changes, or are the physiological
changes more local, such as increased arterial stiffness in the
lower extremities? If the physiological changes are more local,
what caused said physiological changes and how do these
local changes influence systems physiology? For example, what
mechanisms contribute to decreased endothelial function in
the lower extremities, and how does this endothelial function
contribute to myocardial burden. Answering these questions
requires appropriate tool selection.
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TABLE 2 | Research toolbox for investigating the effect of acute sitting exposure on the cardiovascular system.
Outcome Cost Test Rationale
Construct Measure Technology Instrument Consumable Time (min) Skill Reliability
Hemodynamic
Arterial stiffness PWV Oscillometry or
tonometry
>$15 k Negligible 5 Med High Reflects stress placed on arterial wall.
BP (Peripheral) Peripheral Oscillometry <$1 k Negligible 5 Low High Force exerted on a vessel.
BP (Central) PWA Oscillometry >$15 k Negligible 5 Low High Reflects myocardial load.
Blood flow i) Aorta i) CW-US >$40 k Negligible <5 High Med ↓blood flow-induced shear stress induces
endothelial dysfunction.ii) Brain ii) TCD
iii) Peripheral iii) Doppler US
Blood pooling Deoxy[heme] NIRS >$10 k Negligible 5 Med High Reflects blood pooled in venous
compartment.
Endothelial Function FMD US >$40 k Negligible 10 High Med Represents macrovascular dysfunction.
Microvascular Function Reactive hyperemia US >$40 k Negligible 8 High Med Represents microvascular dysfunction
SVR CO/ MAP Finger PPG >$30 k Negligible 1 Low High Moderates blood pooling and venous
return.
Wave reflection PWA Oscillometry >$15 k Negligible 5 Low High Wave reflection increases myocardial load.
Autonomic
PNS HRV ECG >$10 k Negligible 5 Low High Reflects change in PNS activity.
SNS Catecholamines ELISA $500/kit 5 Med High Reflects change in SNS activity.
Hormonal
CACs Venous blood Flow
cytometry
>$20 k $65/person 5 Med High Reflect endothelial repair.
EMPs Venous blood Flow
cytometry
>$20 k $50/person 5 Med High Reflect endothelial damage.
Insulin Venous blood ELISA $500/kit 5 Med High May ↑ SNS activity.
RAAS Venous blood ELISA $500/kit 5 Med High ↑BP.
Metabolic
Glucose Venous blood ELISA $500/kit 5 Med High Reflects glycemic control.
Lipids Venous blood ELISA $500/kit 5 Med High May impair vascular function.
BP, blood pressure; CACs, circulating angiogenic cells; CO, cardiac output; CVD, cardiovascular disease; CW-US, continuous-wave ultrasound; deoxy[heme], deoxygenated heme
concentration; ECG, electrocardiogram; ELISA, enzyme-linked immunosorbent assay; EMPs, endothelial micro-particles; FMD, flow-mediated dilation; HRV, heart rate variability; MAP,
mean arterial pressure; NIRS, near infrared spectroscopy; PNS, parasympathetic nervous system; PPG, photo-plethysmography; PWA, pulse wave analysis; PWV, pulse wave velocity;
RAAS, renin-angiotensin aldosterone system; SB, sedentary behavior; SNS, sympathetic nervous system; SVR, systemic vascular resistance; TCD, transcranial Doppler; US, ultrasound.
Once viable tools have been identified, additional questions
need to be asked. For example, how frequently do the
measurements need to be made to capture the anticipated
physiological response? If the frequency of measurements
is too high, and/or the measurements are too disruptive
to the subject, the subsequent increase in subject arousal
may influence the physiological systems of interest. That is,
the measurements themselves may confound internal validity
(further discussion in Internal Validity Considerations.). For
some measurements, this is not a concern, as they can be
continuously captured without burdening the subject. For
other measurements, such as blood pressure derived using
oscillometry, there will be a burden to the subject. Ideally,
measurements which are potentially disruptive to the subject
are made at baseline and then at the end of the experiment.
However, this brings an additional consideration: which posture
should the measurements made in? Some of the measurements
listed in Table 2 have been validated for use in the supine
posture only and may be less precise in the seated posture.




Endothelial dysfunction is a pivotal, yet potentially reversible
step that precedes and predicts overt CVD (36). This is because
the vascular endothelium is responsible for governing several
aspects of vascular homeostasis, including regulating lipoprotein
permeability, platelet aggregation, and vascular tone (37). A
popular non-invasive test of endothelial function is FMD,
which is quantified as the vasodilatory response to transiently
increased shear stress during reactive hyperemia (Figure 4)
(38). The vasodilatory (expressed as the percentage change in
vessel diameter) and shear stress response can be measured
using commercial duplex Doppler ultrasound coupled with
dedicated image analysis software (e.g., FMD Studio, QUIPU;
or Vascular Tools, Medical Imaging Applications). An important
consideration, and one that will be expanded upon in the Internal
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TABLE 3 | Measurement considerations for studies investigating the effect of acute sitting exposure on the cardiovascular system.
Consideration Example(s) Recommendation(s)
Physiological
Research question Which physiological systems are relevant to the question? Ensure question is clear and addressable.
Multi-system Prolonged sitting impacts multi systems, how can these changes be
accounted for?
Do you need to control or monitor for potential confounders?
Central vs. local Will local physiological changes impact systems physiology? Consider interactions between local and systems physiology and how
this can be controlled/measured.
Stimulus time What duration needed for desired physiological response? Ensure prolonged sitting bout is sufficient for inducing desired
physiology change.
Toolbox selection
Research question Will the tools answer your question? Will the tools measure change in the desired construct?
Level of invasiveness Will invasive measurements arouse the participant? Limit measurement of disruptive/invasive measurements.
Subject burden Will repeated measurements arouse the participant? Limit measures to those pertinent to research question.




Too frequent measurement may act as a stimulus. Limit measure frequency to minimize potential carry-over effect.
Measurement posture Are the measurements validated for use in the measurement posture? Measure under recommended/standardized conditions.
Methodological
Study design Parallel group or randomized cross-over? Provide a rationale for design choice.
Single vs. multi-day Time needed for physiological response? Determine whether a single sitting bout is sufficient to address
question.
Randomization process Which process, and who does it? Third party, blinded to testing conditions, should complete using
established software.
Blinding Should/can the participant and operator be blinded? Blind subjects, researchers, and statisticians where feasible.
Adherence to protocol Will poor adherence reduce the treatment impact? Measure and report protocol adherence. Report missing data.
Power calculations Is the study powered to address the question with respect to the
primary outcome (under proposed testing condition, and specific to
lab/observer)?
Should be pre-planned. Clearly describe calculations.
Statistical Address dropouts, confounders, and clinical inference. Describe statistical procedures in sufficient detail to replicate.
Internal validity
Regression If subjects are selected on basis of extreme scores, will the distribution
regress to mean with repeated testing?
Describe rationale for population selection.
Treatment
randomization
How will the intervention be given from one participant to the next? Randomize treatment allocation
Selection What should be the appropriate control group condition? The control group/condition should be appropriately matched to the
experimental group/condition.
History Is there a carry-over or period effect? Provide rationale for wash-out period and statistically test.
Drop-outs Are those who remain different? Consider intention-to-treat framework or decide strategy for drop-outs
a priori.
Pre-assessment control Consider physical activity and sleep, caffeine, medications and
supplements?
Control and standardize as much as possible. Consider food diaries,
accelerometers and other tools for monitoring.
During assessment
control
Consider environment (temperature, humidity, noise), meal
consumption, fluid replacement, and fidgeting?
Standardize and control environmental conditions.
Instrumentation Consider precision, accuracy, single-observer, measurement posture,
signal interpretation, and covariates?
Ensure choice of instrumentation is appropriate for research
question(s), technicians, participants, and protocols.
External validity
Internal validity Will internal validity compromise external validity? Balance robust methods with the need for generalizability.
Sampling Random sampling and allocation? Provide clear inclusion/exclusion criteria in the methods.
Sex Control for menstrual cycle? Consider whether changes in the menstrual cycle are relevant to your
research question(s) and whether participants need to be in a particular
phase of the cycle or whether this limits generalizability.
Race Will race moderate the effect of prolonged sitting on the outcomes? Provide clear rationale for race stratification and statistical analysis.
Age Will the same sitting interruption strategies work for young and older
populations?
Consider feasibility of strategy in older age groups.
Clinical and Special
Populations
Will the findings generalize to clinical (e.g., Type II diabetes) and special
(e.g., spinal cord injury) population?
Consider whether tested mechanism(s) or sitting reduction strategies
need to be adjusted.
(Continued)
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TABLE 3 | Continued
Consideration Example(s) Recommendation(s)
Ecological validity
Feasibility Will people do the sitting interruption strategy? Consider the balance between mechanistically optimal vs. feasible
sitting interruption strategies.




What other behaviors do people engage while sitting? Consider whether co-occurrence of lifestyle behaviors impact sitting
response
Validity Considerations: Flow-Mediated Dilation section, is that
the FMD test was validated for use in the brachial artery, and
the vasodilatory responsiveness of this artery is thought to be a
barometer of systemic endothelial function (38, 39).
Meta-analytic findings indicate that, after adjusting for
confounding risk factors, a chronic increase of 1% (e.g.,
improving FMD from 6 to 7%) in brachial artery FMD equates
to a 13% (95% confidence interval [CI]: 9–17%) reduction in
the risk of future cardiovascular events (39). Our group recently
conducted a meta-analysis (22 trials, n = 269) to summarize
the effect of acute uninterrupted sitting exposure on FMD%
(25). Uninterrupted prolonged sitting acutely decreased FMD%
(weighted mead difference [WMD] = −2.14 %, 95% CI: −2.69
to −1.59), and sub-group analysis revealed that uninterrupted
decreased lower- but not upper-limb FMD%. Additionally, we
found that sitting interruption increased lower-extremity FMD%
(beneficial) compared to uninterrupted sitting (WMD = 1.91%,
95% CI: 0.40–3.42). Subgroup analysis revealed a moderate but
non-significant effect for aerobic interventions (WMD = 2.17,
95% CI: −0.34 to 4.67) and simple resistance activities (WMD
= 2.40, 95% CI: −0.08 to 4.88) and a trivial effect for standing
interruptions (WMD = 0.24, 95% CI: −0.90 to 1.38). In Internal
Validity Considerations: Flow-Mediated Dilation section we will
explore the internal validity of these findings.
Arterial Stiffness: Pulse-Wave Velocity
Arterial stiffness is dependent on the functional and structural
characteristics of a vessel (15, 22, 23). Functionally, acute
changes in endothelial function influence arterial stiffness
(22, 23). Structurally, arterial stiffness is dependent on the
vessel wall extracellular matrix, including elastin and collagen
(15). Decreased endothelial function and structural remodeling
adversely affect pulsatile hemodynamics, leading to increased
pulsatile stress toward end-organs, including the brain (40,
41), and greater arterial wave reflection with a resultant
increase in myocardial load (15). A number of approaches are
available for measuring arterial stiffness, of which the most
widely used is the PWV between the carotid and femoral
arteries (cfPWV, Figure 5). PWV is the speed at which the
forward pressure wave is transmitted between two arterial
segments, with faster PWV indicative of increased arterial
stiffness. The PWV is traditionally assessed using tonometry,
thoughmore recently oscillometric-based devices have simplified
the measurement procedure. Commercial oscillometric-based
devices automate PWV calculations, confer excellent reliability
(intra-class correlation coefficient [ICC]: 0.98), and compare the
outcome to known reference values (Figure 5) (42).
A meta-analysis of 17 longitudinal studies (n = 15,877, mean
follow-up 7.7 years) reported that for a 1 m/s increase in
cfPWV, the risk of future cardiovascular events, cardiovascular
mortality, and all-cause mortality increased by 14, 15, and 15%,
respectively (43). Our group has reported that uninterrupted
prolonged sitting acutely increases cfPWV by 0.2–0.4 m/s (11–
14). These changes may seem small in relation to a 1 m/s
clinical cut point, but that cut-point is for chronic and not acute
changes in cfPWV. The chronic changes in cfPWV are likely
driven predominantly by changes in vessel structural, whereas the
acute changes in cfPWV are mostly likely driven vessel function.
In support, our group and others have reported that acute
decreases in endothelial function are associated with increased
arterial stiffness (20–22). The importance of these acute—
and likely regular—SB-induced increases in cfPWV warrants
further research. Additionally, further research is warranted
to understand the pathophysiological implications of the 62%
reduction if cfPWV we have reported when participants stand
30-min once/h decreased cfPWV by 62% vs. sitting only (11).
METHODOLOGICAL CONSIDERATIONS
An example timeline for an acute sitting study is shown
in Figure 6. This is for a single-day, uninterrupted sitting
study design. Whether or not a single day is sufficient is
dependent on the research question, the proposed mechanism(s),
and the primary outcome. If a multiple-day protocol is
required, consideration should be given to adherence to
protocol, including the ability to measure adherence (i.e.,
via use of accelerometry). In the Figure 6 example the
primary outcome, cfPWV, is part of the non-continuous
battery of assessments (Figure 6B). These measurements are
ordered with consideration to the chance of one measurement
confounding the next. Continuous measurements may include
blood pressure via volume-clamp plethysmography and heart
rate via electrocardiogram. In this example, the non-continuous
measurements are made pre- and post-sitting in the supine
position, as well as each hour during the sitting bout. Though
in accordance with recommendations for cfPWV assessments,
hypothesis testing is based on measurements made in the supine
position (44, 45). Measurements made in the seated position are
used for monitoring trends, though repeated testing should be
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FIGURE 4 | Schematic of the flow-mediated dilation (FMD) test. (A) Shear stress created by red blood cells flowing past the vessel wall is detected by
mechanoreceptors in the endothelium, triggering a signal cascade whereby vasodilators, nitric oxide (NO) prostacyclin (PGI2) and endothelial hyperpolarizing factor
(EDHF) are produced. Vasodilators subsequently diffuse to the vascular smooth muscle cells, prompting vasodilation. (B) Vessel diameter and shear rate responses
before and after 5-min ischaemic stimulus. eNOS, endothelial nitric oxide synthase; COX-2, cyclooxygenase-2.
carefully considered as the measurement itself may confound the
study outcomes (discussed further below).
The timeline shown in Figure 6 indicates one condition,
uninterrupted sitting. However, it is highly likely that a researcher
will want to compare this uninterrupted sitting condition to
another condition, such as a strategy to interrupt sitting. For this
scenario a decision has to be made as to whether a parallel group
RCT design or cross-over study design is used. For practical
reasons an RCT may not be feasible, as such designs require
large sample sizes, and it is likely that—considering the time
requirement—a given laboratory can test only one subject per
day. For this reason, cross-over trials have commonly been
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FIGURE 5 | Schematic of carotid-femoral pulse-wave velocity (cfPWV). The cfPWV is calculated by dividing path length (D) by pulse transit time (PTT). The PTT is
estimated as the difference in time (t) between the proximal (carotid artery) pressure waveform (t1) and distal (femoral artery) pressure waveform (t2).
used in the literature (11–14). This design permits each subject
to serve as their own control, thereby eliminating between-
subject variation as a statistical consideration and substantially
increasing statistical efficiency. However, as will be discussed in
Internal Validity the potential for a carry-over effect needs to be
factored into the time between testing sessions. For both types of
study design, consideration also needs to be given to treatment
randomization. Randomizing subjects to control and treatment
groups ensures that allocation to exposure is not determined
by a third variable, which itself may influence the outcome.
Ideally, consideration is given to both random allocation and
random sampling, where random allocation is used to increase
internal validity (see section Internal Validity) and random
sampling increases generalizability (see section External Validity)
to the population of interest. For acute sitting-based studies it
is difficult, if not impossible, to blind the subject and research
technician to the order of testing. However, the subjects and
researcher technicians can be blinded to the condition until each
day of testing, and the statistician and any technicians processing
outcome data should be blinded.
Cross-over designs pose some additional statistical challenges.
One challenge is loss to follow-up, and an additional challenge
is accounting for confounders. With respect to loss to follow-
up, this can occur when a given subject does not complete
all testing days. A confounder is a variable that influences
both the dependent variable and independent variable, causing
a spurious association. For example, mean arterial pressure
(MAP) is an important determinant of PWV (45). A change
in MAP during and between each experiment testing day may
confound the relationship between the sitting condition(s) and
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FIGURE 6 | Example experimental protocol for an acute sitting study. (A) Indicates the time for a 3-h sitting study. Upon arrival to the laboratory the subject consumes
a standard small meal/snack and venous blood is collected. The subject then rests quietly in the supine posture for 20-min prior to passive transfer to the seated
posture. At the end of the 3-h sitting bout the subject is transferred back to the supine posture. Primary outcomes are collected in the supine posture. The cross
marks indicate the measurement timepoints. (B) Indicates example non-continuous outcomes, including ultrasound (US)-derived leg blood flow (BF) and carotid
arterial stiffness (AS), pulse wave velocity (PWV)-derived aortic (carotid-femoral)- and leg (thigh-ankle)-AS, and pulse wave analysis (PWA)-derived central blood
pressure (CBP).
PWV. Collectively, these examples illustrate that the statistical
strategy should be able to cope with missing data as well as
time varying covariates. For these reasons mixed models have
gained popularity.
While the statistical model is important, careful consideration
should also be given to clinical inference. Clinical inference refers
to whether a “significant” result is clinically beneficial or harmful.
A p-value provides insight into whether or not the data are
statistically significant within the context of the target population,
i.e., the probability that the observed magnitude of difference for
the sample is different than that of the intended target population,
but does not provide information about clinical significance, i.e.,
whether the findings are likely to be meaningful with regards to
physiology or pathophysiology (46). The practice of including
statistical and clinical significance allows scientists to better infer
the clinical and practical viability of study findings, which in turn
will assist in translating the findings.
The magnitude of a clinically significant difference should
be considered when making the study power calculation, i.e.,
the minimum sample size required to detect a true effect.
Additional considerations include the importance of type I
error (alpha level), which refers to incorrectly rejecting the
null hypothesis, and type II errors (beta level), which refers to
incorrectly accepting the null hypothesis. Lastly, the precision of
the instrument selected to measure the primary outcome should
be considered. This precision should be specific to the laboratory
setting and observer, and specific to the testing conditions—
particularly if measurements are made under non-standard
conditions. For example, if FMD and PWV are measured in
the seated posture, the precision estimates determined in the
supine posture may not be appropriate. Additionally, as will be
discussed in the next section, when measurements are made in
the seated posture the device assumptions may be violated and
measurement accuracy may be reduced.
INTERNAL VALIDITY
The term “validity” is most commonly used in the context of
the accuracy of a measurement tool, e.g., does a particular PWV
device truly reflect the arterial stiffness of the segment of interest.
However, validity also has a related meaning when it comes to
the design of a study. There are two classes of threat to the
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validity of a study—internal validity and external validity. In the
next section, we will discuss external validity. Here we focus
on internal validity, which is concerned with the rigor (degree
of control) of the study design. Controlling for confounding
variables minimizes the potential for an alternative explanation
for treatment effects and provides more confidence that any
effects are due to the independent variable. For example, a study
with high internal validity will control for the factors that may
confound the true effect of acute prolonged sitting (independent)
on the cardiovascular system (dependent variable).
The first set of threats to internal validity pertain to
population. First, there is the threat of regression to the mean,
which occurs when subjects have been selected on the basis
of extreme scores, e.g., low and/or high FMD scores. With
repeated testing, extreme (low and high) scores in a distribution
tend to move closer to the mean, i.e., they regress (47). The
second threat is treatment allocation. There should be an equal
chance of allocation to each experimental condition, which can
be controlled using randomization. In the case of cross-over trials,
the order of conditions should be randomized. This process will
help to control the confounding impact of the third threat, the
“carry-over effect,” i.e., treatment one influencing the outcome
for treatment two. However, while condition randomization will
help to minimize this threat, attention also needs to be given to
the minimum wash-out period to reduce any carry-over effect.
Depending on the intervention conditions, it is likely that any
carry-over effects can be “washed-out” with a minimal number of
days. Third, consideration should be given to the control group.
Control groups strongly affect inferences drawn from a study
by ensuring that the interventional effects are beyond normal
variation. In the case of a parallel group design, the control group
should be appropriately matched to the experimental group(s).
For cross-over designs the primary consideration is the control
condition. That is, what is the appropriate control condition
when investigating the effects of acute prolonged sitting on the
cardiovascular system? Fourth, consideration needs to be given
to drop-out, especially if those who drop-out from a study are
different from those who remain in the study. This is a particular
concern if a parallel group design is used, as drop-out may result
in the groups no longer being matched.
The second set of threats pertain to extraneous factors
that may confound the relationship between the variables of
interest. These threats can be controlled through the appropriate
employment of pre-assessment guidelines, and consideration to
the environmental conditions during-assessment. Since vascular
function is influenced by circadian and diurnal variation, it
is typical to control experimental time of day with further
consideration to the minimum number of awake hours prior
to testing (48, 49). Additionally, changes in lifestyle behaviors
can influence vascular function, including sleep, prior physical
activity, and diet. While sleep has not traditionally been
considered a component of pre-assessment control, arterial
stiffness has been reported to increase following acute sleep
deprivation (50). Therefore, in addition to establishing a
minimum number of awake hours it may be beneficial to ask
subjects to go to bed at the same time between visits. Dietary
control may include providing a standardized meal for the night
prior to testing and asking the subjects to report for testing having
fasted. The fasted state is a typical requirement for vascular health
testing as different macro- and micro-nutrients can greatly affect
vascular function (51, 52). However, for studies incorporating
long testing-day conditions, the fasted state may not be feasible.
Additionally, having subjects fast may be unethical for certain
population groups, such as type II diabetics who are at risk
for hypoglycemia. For the aforementioned scenarios, careful
consideration needs to be given to the timing and composition of
the meal provided prior to testing. Ideally, to ensure consistency
between testing sessions, the pre-assessment control factors
should be actively monitored, including through the use of
accelerometry to monitor physical activity and sleep, and diaries
and continuous glucose monitors to monitor diet.
During-assessment, it is important to control environmental
conditions, including ambient noise and temperature. Ambient
noise may raise arousal, whilst core temperature and skin
temperature have both been reported to affect vascular function
(53). Fluid replacement should also be considered. Over a
prolonged period, there will be insensible water loss, which
could lead to a drop-in blood pressure, activate renin-angiotensin
aldosterone system and confound the vascular outcome. As such,
it important to estimate predicted water loss and put in place
a strategy for water replacement. Lastly, considerations should
be given to what subjects do and how they behave during the
study. In terms of what they do, should they be permitted to
engage in their typical desk work (e.g., homework assignment),
or should they watch a non-stimulatory documentary to keep
the subject awake while minimizing arousal? In terms of
behavior, consideration needs to be given to bathroom breaks
and how this is controlled for between study visits, as well as
incidental movement (e.g., fidgeting) during the study. Ideally
an accelerometer is worn on the ankle during the study so that
movement can be used as a statistical covariate if needed.
The final set of threats pertains to instrumentation. To
investigate the relationship between an independent and
dependent variable, an instrument should be able to capture
changes in the dependent variable with acceptable accuracy
(validity) and precision (reliability). Moreover, it is important
that the observer can report acceptable accuracy and precision
in their laboratory setting, under the clearly articulated study
conditions. For example, if measurements are made in the seated
posture the accuracy and precision of measurements in said
posture should be reported and used to determine statistical
power. We have previously reported that both the seated posture
and the non-fasted state decrease the precision of blood pressure
and arterial wave reflection readings (54, 55). Additionally, we
have reported that changing arm position relative to heart level
impacted the generalized transfer function used for pulse wave
analysis (56). Lastly, if measurements are made under non-
standard conditions (i.e., with respect to guidelines, operating
manual, and/or previous validation studies), it is important
to understand the device assumptions and whether the non-
standard conditions violate these assumptions. For example,
pulse wave analysis is commonly used to measure augmentation
index, an estimate of arterial wave reflection. One determinant of
arterial wave reflection is arterial stiffness, and it may be expected
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that increased arterial stiffness during a bout of prolonged
sitting would increase arterial wave reflection. However, we have
reported a paradoxical decrease in augmentation index during
prolonged sitting (12, 14).We rationalized that the decrease was a
function of blood pooling in the lower-extremities, which would
dampen the pressure wave.
Flow-Mediated Dilation
As noted above, there has been interest on the effects of acute
prolonged sitting on FMD as a measure of endothelial function.
Our recent meta-analysis found that uninterrupted prolonged
sitting decreased lower- but not upper-limb FMD (25). However,
in interpreting these findings several considerations should be
made, including accuracy, precision, the test assumptions, and
measurement posture. Recall that accuracy refers to the closeness
of a measurement to a known construct. The FMD test was
originally validated by Celermajer et al. (57) for use in the brachial
(upper-arm) artery, and shortly thereafter brachial artery FMD
was validated against invasively assessed endothelial function in
the coronary arteries (58). Subsequently, brachial FMD has been
shown to be regulated by endothelium-derived molecules, most
notably nitric oxide (NO) (59). As such, we have a good idea as to
what brachial artery FMD is telling us (i.e., its validity). However,
we know little about the accuracy of lower-limb FMD. Further,
we know little about the precision of lower-limb FMD. One study
has estimated the precision of popliteal artery FMD, reporting
an ICC of 0.25 (60). To put this into context, we calculated the
standard error of measurement from this aforementioned study
to be 1.74%, meaning that for an average baseline FMD of 4.1%,
a relative change exceeding 42% (i.e., 4.1–6.0%) would have to be
observed to detect a true effect (61).
Test assumptions and measurement posture will be
considered collectively. A major assumption is that the
predominant stimuli regulating the FMD response (i.e., change
in vessel tone) is the increase in shear stress during reactive
hyperemia (38, 62). Shear stress is determined by red blood
cells moving close to endothelial cells (see Figure 4B). As
the fluid particles “travel” through the lumen, their velocity
increases from zero at the vessel wall to a maximum value at
the center of the vessel. This leads to the establishment of a
gradient, which is defined as shear stress. Shear stress therefore
acts at a tangent to the wall to create a frictional force at the
surface of the endothelium. The endothelial cells are equipped
with mechanosensors to detect this stress, enabling vascular
tissues to respond with acute adjustments in vascular tone (59).
This vasodilatory response reflects alterations in the rate of
production of endothelial-derived mediators, including NO (59).
NO performs a myriad of anti-atherogenic functions and is
considered the most important molecule governing endothelial
function and health (59). Therefore, it is assumed that FMD acts
as a barometer of the bioavailability of these anti-atherosclerotic
NO molecules. Ideally though, the vasodilatory response is
adjusted for the shear stress stimulus. Fortunately, the duplex
Doppler ultrasound equipment used for FMD can also estimate
shear stress as the product of the shear rate and blood viscosity,
where shear rate is estimated using an equation based on
Poiseuille’s law (38, 62). A major assumption of Poiseuille’s law
is that the velocity profile is parabolic, as depicted in Figure 4B.
The velocity profile will generally not develop to a full parabola
as a consequence of flow unsteadiness and short vessel entrance
lengths, but the underestimation is likely not pronounced when
resting in the supine position (63). However, in the seated
posture, the shear stress profile in the lower-extremities (e.g.,
femoral or popliteal artery) may become turbulent during
reactive hyperemia as a function of increased vessel tortuosity
and hydrostatic pressure (64).
An alternative to taking FMD measurement in the seated
posture is to take the measurements in the supine posture.
Measurements in the supine posture are likely to be more
accurate and precise, not only because of greater likelihood
of capturing the true shear stress stimulus, but also because
the measurements are less technically challenging. However,
the caveat is that following the transition from the seated
to supine posture, a short period of time, e.g., 10min, will
be required to ensure hemodynamic stability prior to FMD
assessment. This may be particularly problematic for sitting
interruption studies, as it will extend the time between
the last interruption and the FMD assessment and, will
likely mask the true interaction effect between prolonged
sitting and the sitting interruption strategy. Conversely, by
assessing FMD within 10min of the final interruption (65),
it could be argued that the subsequent elevation in shear
stress as a consequence of the interruption will also mask
the true effect of prolonged sitting. The optimal conditions
for assessing the FMD response to prolonged sitting require
careful consideration.
Pulse-Wave Velocity
As with FMD assessments, accepted guidelines recommend
measuring PWV in the supine posture (45). Additionally, as
with any methodology, we should consider accuracy—what is
the measurement reflecting? PWV, which is an estimate of
arterial stiffness, is dependent on the functional and structural
characteristics of a vessel (15, 22, 23). With prolonged sitting it
is likely that changes in PWV reflect changes in vessel function.
However, it should be considered that the device algorithm was
validated in the supine posture (66), and that any changes in
PWV in the seated posture may be confounded by changes in
autonomic balance. During orthostasis there is a propensity for
blood to pool in the sub-diaphragmatic venous system (67). To
compensate for blood pooling, and attempt to ensure adequate
venous return, the baroreflex response leads to increased lower
extremity vascular tone (68). The increase in vascular tone leads
to the fixed vessel mass being squeezed into a smaller space, which
would increase PWV. To control for this potential confounding
PWV should be adjusted for within-condition changes in MAP.
However, it should be considered that the adjustment for MAP
may not completely control for the confounding as it is a
systemic rather than local measure. MAP does increase with
vascular tone, but vascular tone is regulated by both autonomic
and local factors, and that regulatory factors may differ
by vessel segment.
Our group has compared PWV measures in the supine and
seated posture (in review). The cfPWV was measured in the
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seated and supine postures prior to and following 3-h sitting in
18 young adults (mean age: 23 years, standard deviation [SD: 3]
years). We found a posture effect, with higher cfPWV (β = 1.7
[SD: 0.14] m/s, p = 0.001) in the seated posture. However, no
posture by time interaction effects were observed, with cfPWV
changing similarly over time measures across postures. Across
postures, we calculated an agreement of ICC = 0.77 (95%CI:
0.63–0.86) for cfPWV measurements made in supine and seated
postures. In a separate study, carotid-radial (cr) PWV and
carotid-ankle (ca) PWV were measured in the seated and supine
postures prior to and following 7.5 h of sitting in 25 middle-aged
adults (42 [SD: 12] years) (69). We again found a posture effect,
with higher crPWV (β = 0.43 m/s, standard error [SE: 0.13],
p = 0.001) and caPWV (β = 2.04 [SE: 0.17] m/s, p = 0.001)
in the seated posture, but no posture by time interaction effect.
Similarly, in 20 young adults (26 [SD: 8] years) we compared
supine and seated caPWV and crPWV response to a caffeine
perturbation, and found posture effects for caPWV (β = 0.55
m/s, p < 0.001) and caPWV (β = 3.59 m/s, p < 0.001), but no
posture by time interaction effects (70). We also reported that
crPWV (ICC: 0.77 vs. 0.64) and caPWV (ICC: 0.76 vs. 0.36)
were more precise in the seated vs. supine posture (70), but that
femoral-ankle PWV (faPWV) had acceptable precision in the
supine (ICC: 0.83), but not seated posture (ICC = 0.29) (61).
A poorer faPWV in a seated posture may be a consequence
of orthostasis induced blood pooling compromising waveform
detection. In summary, assessment posture does impact absolute
PWV measures, but appears not to affect the observed response
to prolonged sitting.
The standard measure of PWV is cfPWV, which represents
the aorto-illiac pathway (15). This measure is particularly
appealing because cfPWV is strongly associated with the risk
of cardiovascular events (43), and international reference norms
have been established for population, age, and risk factor
strata (71). However, cfPWV assessments typically require
applanation of the carotid artery. This can be technically
challenging in certain populations, including persons who are
obese and those with advanced carotid artery atherosclerosis (72),
and accuracy may be compromised. Additionally, applanation
of the carotid artery can result in a pressor reflex, which
can become problematic with repeated measurements as the
measurement itself may confound the study outcomes. An
alternative PWVmeasure is heart-femoral PWV, here the “heart”
portion can be determined from an electrocardiogram and/or
a phonocardiogram. We recently found good (73) (r > 0.75)
agreement between hfPWV and cfPWV (r= 0.83) in 4,133 older-
aged (75 [SD: 5] years) adults) (74), and we also found that
these measures responded similarly (r = 0.92) to an orthostatic
challenge (modified tilt-table test), a perturbation known to
impact aortic arterial stiffness (75). An additional alternative is
brachial-femoral PWV (bfPWV), which can be obtained using
oscillometric cuffs placed around the upper arm and upper
thigh. Recently, we assessed bfPWV and cfPWV in the seated
and supine postures prior to and following 3 h of sitting in 18
young adults (23 [SD: 3] years) and found acceptable overall
agreement between the two measures (ICC: 0.74, 95%CI: 0.69–
0.84) (in review).
EXTERNAL VALIDITY
External validity refers to whether your study results, obtained
from a sample of the population of interest, can be generalized to
the population at large. There is a reciprocal relationship between
the external and internal validity, in that controlling for one
often comes at the cost of the other. For example, with respect
to acute sitting-based studies, the research setting is typically
constrained to maximize internal validity. For example, it is
common to control for population age, sex, time of day, diet,
prior physical activity, and activities permitted during the study
(e.g., use of the arms and legs). These factors are controlled so
that the underlying causes of a phenomena can be established.
However, in the real-world setting, the controlled variables
may impact the relationship between prolonged sitting and the
particular outcome of interest. Therefore, it is recommended
that once a particular phenomenon has been established,
subsequent consideration should be given to understanding
whether said phenomena persists when extended to more
presentative populations and settings. Two additional factors,
which should be considered irrespective of the desired balance
between internal validity and external validity are population
sampling and population demographics.
As discussed above, the randomization component of an
RCT is typically synonymous with the process through which
subjects are allocated to groups. However, this process controls
internal validity. To ensure external validity the population of
interest should be randomly sampled (47). A number of sitting-
based studies have used convenience sampling. That is, they have
conducted the study using readily available higher education
students. This is not surprising given the resources required to
conduct acute sitting studies and the costs required for random
sampling. However, with convenience sampling, individuals may
not be representative of the larger population, thus, affecting both
internal and external validity. To enable the reader to discern the
generalizability of findings, the methods section should provide
clear details about sampling and group allocations as well as
inclusion and exclusion criteria, the results section should clearly
articulate the sampling process and demographic characteristics,
and the discussion section should contextualize who the study
findings can be generalized to Slack and Draugalis (47).
Demographic considerations include age, race, and sex. Older
adults (aged > 65 years) exhibit greater SB, with a recent
meta-analysis indicating that older people are sedentary for
65–80% of their waking time (76). However, it is currently
unknown whether the cardiovascular effects of acute prolonged
sitting exposure differ in older compared to younger adults, and
whether specific sitting interruption strategies are required to
mitigate any unique negative cardiovascular effects. Similarly,
we know that CVD mortality rate differs by race (77), but we
do not know whether race interacts with the effects of repeated
prolonged sitting exposure on the cardiovascular system. An
additional consideration is sex. Men and women have different
trajectories for the acquisition of CVD over the life course
(78, 79). However, little is known about the effects of acute
prolonged sitting exposure on the cardiovascular system in
men vs. women (80). Further, because fluctuations in estrogen
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can affect cardiovascular measures, women are typically studied
during the first 1–7 days of their menstrual cycle, or during the
placebo week of contraceptive use. Controlling the stage at which
women are tested increases internal validity, but at the expense
of external validity. Although challenging experimentally, since
larger sample sizes and/or more testing sessions will be required,
it is important to understand the effects of repeated prolonged
sitting exposure across the menstrual cycle so that we can better
understand any unique sex effects.
To this point, we have discussed general population sampling
and demographic issues, but attention should also be paid to
clinical populations. For example, CVD is a major concern
in people with Type II diabetes, and it is likely that this
population will benefit from the hemodynamic effects of sitting
interruption strategies. However, special attention needs to be
given to glycemic control. Compared to fasting plasma glucose
or glycated hemoglobin levels, hyperglycemic spikes are more
strongly associated with CVD in this population (81), and the
greatest hyperglycemic spikes occur following the consumption
of each daily ad libitummeal (82). These spikes trigger oxidative
stress, elevate inflammatory cytokines, reduce NO bioavailability,
and induce endothelial dysfunction (32, 81, 83). As such, it may
be particularly important to plan sitting interruption strategies
around meal times in this group. Further, if glycemic control
is the key regulatory mechanism, sitting interruption strategies
should specifically target reductions in post-prandial glucose.
Recently, the WHO released the first global physical activity
and SB guidelines for people living with disability (84). With
respect to SB, similar to guidelines published for the general
population (2, 3), the advice for reducing SB is vague and
non-specific. When designing acute SB studies to address the
gaps in knowledge, we need to consider that certain disabilities
may preclude these individuals from interrupting SB through
conventional means, and that these individuals may be at
heightened risk for CMD. For example, one study using data
from the Canadian Community Health Survey reported that
the prevalence of heart disease (odds ratio [OR]: 2.7, 95%CI:
1.9–3.8) and stroke (OR: 3.7, 95%CI: 2.2–6.2) is much higher
among those with a spinal cord injury (SCI) compared to those
without (85). We have previously reported that the legs in in
individuals with SCI are particularly susceptible to poor vascular
health (86). A likely contributing factor is that persons with
SCI may not be able to voluntarily contract skeletal muscle
in their lower limbs, which limits hemodynamic stressors in
this region, including decreased shear stress. To help lessen
or reverse these regional abnormalities novel strategies will be
required, of which regular sitting interruption may be a viable
option. However, the strategies used to interrupt sitting behavior
in able-bodied individuals are unlikely to be a suitable option.
One potential alternative strategy is neuromuscular electrical
stimulation to engage the lower-extremity musculature (87), and
an additional is intermittent pneumatic compression therapy.
The latter therapy, which is typically used to treat patients with
peripheral arterial disease, can be used to raise lower extremity
vascular shear stress. We recently reported that a single 60min
bout of intermittent pneumatic compression therapy acutely
increased posterior tibial artery FMD by 31% (88).
ECOLOGICAL VALIDITY
Ecological validity tells us whether or not our findings can
be generalized to real-world or naturalistic settings. To put
this concept into perspective, it is important to understand
the mechanisms linking repeated prolonged sitting exposure
to increased CVD risk, so that optimal sitting interruption
prescription can be identified with respect to the FITT
(frequency, intensity, time, and type) principle. However, the
optimal FITT prescription will do little to lessen CVD risk
if there is poor adherence to the prescription. As such there
needs to be some compromise between what is considered to
be the physiological optimal prescription vs. what people will
actually do. For example, it is common practice to standardize
the time of day when conducting an acute sitting-based study.
This standardization is important to internal validity as circadian
and diurnal variation can affect vascular outcomes (48, 49). In
practice, this means our knowledge about the effects of prolonged
sitting on the cardiovascular system are limited to effects that
occur during the morning. We know little pertaining to whether
these cardiovascular responses differ across the day, or whether
sitting interruption strategies need to differ across the day to
mitigate varying cardiovascular responses. Further, it is unclear
if people will adhere to sitting interruption across the day,
especially if these interruption strategies need to be varied.
A final consideration is the interaction with additional lifestyle
behaviors. When people exercise, they tend to just exercise.
This means that an optimal FITT prescription can be applied
with limited consideration to other lifestyle behaviors. The same
cannot be said for sitting behavior. People tend to engage in
other behaviors while they are sitting, including consuming
meals and performing stressful activities. This complicates both
our physiological understanding and how we prescribe sitting
interruption strategies. For example, we recently found that,
in young healthy men (n = 13, 22 [SD: 2] years), combining
prolonged sitting (3 h) with the consumption of a high-fat meal
led to a greater increase in cfPWV (0.59 m/s, 95%CI: 0.29–
0.89, Cohen’s d = 1.12) when compared to a low-fat meal
(0.14 m/s, 95%CI: 0.05–0.34, Cohen’s d = 0.44) (in review).
Additionally, in young, healthy adults (n = 18, 22.6 [SD: 3.1]
years, 33% female) we investigated the effects of prolonged sitting
(3 h) combined with the consumption of high- or low-glycemic
index meal (26). Global PWV (a measure incorporating cf-,
bf- and fa-PWV) increased by 0.29 m/s (95%CI: 0.14–0.45, d
= 0.25), with a non-significant time effect. However, glucose
variability was significantly correlated with bfPWV (r = 0.52,
95%CI: 0.19–0.71). In sum, these limited data indicate that special
attention to concomitant lifestyle behaviors may be required
when prescribing sitting interruption strategies.
TRANSLATION
Ultimately, the goal of sitting-based research should be to inform
policy that benefits the health of our societies. To provide context
to this section, here we detail the considerations applied by theUS
Preventive Services Task Force (USPSF) when developing policy.
The target audience of the USPSF is primary care clinicians,
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and its focus is conditions that cause a large burden of suffering
to society and that also have available a potentially effective
preventive service (89). In developing policy, the USPTF utilize
a process similar to that used by many evidence-based groups,
which is to systematically review the research literature and judge
the strength of the evidence. TheUSPSTF assigns a grade ranging:
from A (strongly recommended) to D (recommend against), or I
(insufficient evidence) (89). This grade is assigned following three
strata of admissible evidence, as follows: (i) individual studies
(study design, internal validity); (ii) the linkage between each key
question (aggregate internal validity, aggregate external validity,
and coherence/consistency); and (iii) whether the evidence is
adequate to determine the existence and magnitude of a causal
connection between the preventive service and health outcomes.
With respect to (i) individual studies, it is common for evidence-
based groups to adjudicate the strength of individual studies
based on a hierarchical grading system similar to that presented
in Figure 2. This grading systems typically assigns the highest
grade to RCTs (89). The USPSTF has extended their appraisal
system to also consider RCTs cohort studies, case-control studies,
and diagnostic accuracy studies (89). When appraising these
studies, the USPSTF now separately rates the study design as
well as internal and external validity (89). With respect to (ii)
the linkage between each key question, the USPSTF considers
aggregate internal- and external-validity, and the coherence
of the body of evidence. Last, the USPSTF considers (iii)
whether the evidence is adequate to determine the existence and
magnitude of a causal connection between the preventive service
and health outcomes. This includes assessing the magnitude of
net benefit, in either words do the benefits outweigh potential
harms? Additionally, in accordance with other agencies, the
USPSTF considers the likelihood of a biologically plausible
mechanism between cause and effect (89–91).
One such policy developed by the USPSTF is: “Healthful Diet
and Physical Activity for Cardiovascular Disease Prevention
in Adults With Cardiovascular Risk Factors: Behavioral
Counseling” (92). The physical activity recommendation
received a B grade—a recommendation that the service is
routinely provided. Now consider that the first physical activity
study was conducted in the 1950s (10), and since this time many
well-controlled (internally-valid) RCTs have been conducted
across numerous populations, and there is ample evidence to
support net benefit to cardiovascular health (2). The sitting-based
literature is currently void of well-designed cohort and RCTs
that test mechanism-informed sitting interruption strategies.
A major reason for this is a lack of true understanding of
the effects of repeated exposure to uninterrupted prolonged
sitting on the cardiovascular system. We need studies with high
internal validity to assess mechanisms (biological plausibility)
and to identify sitting interruption strategies that directly tackle
the mechanisms of action. Establishing biological plausibility
will facilitate the design of well-controlled RCTs that can be
replicated across populations. Using the Pyramid of Clinical
Evidence (Figure 2), we are currently sitting somewhere toward
the bottom of the pyramid looking up. Accumulating the
necessary evidence will take time and resources; physical activity
did not receive such a lofty status over-night, but such status
does shine a path.
CONCLUSIONS
While leading public health agencies have begun to advocate
a “reduction” in sitting behavior, these guidelines are typically
vague and non-specific. The lack of specific guidelines for
interrupting prolonged sitting bouts is attributable to the lack of
available robust evidence to facilitate guideline development. To
inform policy, well-designed RCTs are required to test the efficacy
of specific and translatable sitting reduction strategies. To assist
in the design of RCTs, this review postulated that several gaps in
the literature first need to be filled, including the design of acute
prolonged sitting-based studies that are internally valid and help
to establish biological plausibility. The establishment of biological
plausibility will assist the development of RCTs that target the
mechanisms through which repeated sitting exposures stress
the cardiovascular system. At present, we are some ways from
developing specific sitting interruption guidelines. However, if, as
a research community we consider the steps necessary to design
well-controlled sitting exposure studies, while contemplating
the criteria used to aid policy development, we can accelerate
guideline development.
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